Protein kinase inhibitors

59 subordinate codes

• XM5W30Imatinib
• XM3A37Gefitinib
• XM3420Erlotinib
• XM1982Sunitinib
• XM4A57Sorafenib
• XM50U1Dasatinib
• XM1FM4Lapatinib
• XM6BP0Nilotinib
• XM93U4Temsirolimus
• XM69S5Everolimus
• XM4FT3Pazopanib
• XM3W52Vandetanib
• XM7917Afatinib
• XM60L5Bosutinib
• XM55B8Vemurafenib
• XM2U80Crizotinib
• XM6JL9Axitinib
• XM0853Ruxolitinib
• XM0SL6Ridaforolimus
• XM0601Regorafenib
• XM0JZ7Masitinib
• XM1HB8Dabrafenib
• XM70G2Ponatinib
• XM7VJ9Trametinib
• XM4TL0Cabozantinib
• XM0C70Ibrutinib
• XM14D3Ceritinib
• XM7ZH9Lenvatinib
• XM4EA3Nintedanib
• XM2QS0Cediranib
• XM4K70Palbociclib
• XM8B31Tivozanib
• XM8YD2Osimertinib
• XM4JL2Alectinib
• XM21J7Rociletinib
• XM6K99Cobimetinib
• XM5Y46Midostaurin
• XM0J75Olmutinib
• XM3YP5Binimetinib
• XM2RL4Ribociclib
• XM2DD8Brigatinib
• XM59V9Lorlatinib
• XM5MT6Neratinib
• XM5RQ2Encorafenib
• XM15D6Dacomitinib
• XM9L11Icotinib
• XM8E34Abemaciclib
• XM09W7Acalabrutinib
• XM1L31Quizartinib
• XM2LF4Larotrectinib
• XM4BT2Gilteritinib
• XM16Z9Entrectinib
• XM28Z0Fedratinib
• XM7168Asciminib
• XM7380Pacritinib
• XM9U75Infigratinib
• XM9XE8Futibatinib
• XM74A3Selpercatinib
• XM1UG8Pralsetinib

Also indexed as

Nearby in Antineoplastic agents

• XM09D9Alkylating agents
• Antineoplastic antimetabolites
• Antineoplastic natural products and derivatives
• XM4DQ7Cytotoxic antibiotics and related substances
• Monoclonal antibodies
• XM3T47Sensitizers used in photodynamic or radiation therapy
• Other antineoplastic drugs
• XM1JG6Monoclonal antibodies and antibody drug conjugates